Pzena Investment Management
REGN icon

Pzena Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Pzena Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-794
Closed -$547K – 190
2022
Q3 		$547K Sell
794
-325
-29% -$205K ﹤0.01% 149
2022
Q2 		$661K Buy
1,119
+195
+21% +$127K ﹤0.01% 135
2022
Q1 		$645K Buy
924
+20
+2% +$12.7K ﹤0.01% 145
2021
Q4 		$571K Sell
904
-73
-7% -$44.9K ﹤0.01% 149
2021
Q3 		$591K Sell
977
-137
-12% -$85.1K ﹤0.01% 143
2021
Q2 		$622K Sell
1,114
-141
-11% -$71.4K ﹤0.01% 139
2021
Q1 		$594K Buy
+1,255
New +$611K ﹤0.01% 153

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Pzena Investment Management's REGN Position: Q4 2022 in Review

Pzena Investment Management sold out of Regeneron Pharmaceuticals (REGN) in Q4 2022, closing a stake of 794 shares — an estimated $547K sold.

Pzena Investment Management first reported a position in REGN in Q1 2021 and held it in 7 quarters. The position peaked at $661K in Q2 2022. 1,158 funds tracked by Wall St. Rank hold REGN as of Q4 2022.

  • Pzena Investment Management reported no remaining Regeneron Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Pzena Investment Management sold 794 Regeneron Pharmaceuticals shares in Q4 2022, an estimated $547K.
  • Pzena Investment Management first reported a position in Regeneron Pharmaceuticals in Q1 2021 and held it in 7 quarters.
  • Pzena Investment Management's Regeneron Pharmaceuticals position peaked at $661K in Q2 2022.
  • 1,158 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2022.

Based on Pzena Investment Management's 13F filing for Q4 2022, filed 3 Feb 2023.